Welcome Guest
Home > Clinical Genitourinary Cancer > Volume 5 |  Issue 7

Table of Contents

Volume 5 |  Issue 7

Publication Date: December 2007
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Editorial
Page Number of this Article in the Print Version
420-421		 Survival Analyses Overview in Hormone-Refractory Prostate Cancer Clinical Trials in the Prostate-Specific Antigen Era
Oliver Sartor
  • Abstract
  • No Access
  • Add to Cart
Comprehensive Review
Page Number of this Article in the Print Version
422-426		 Inhibition of DNA Methylation by Antisense Oligonucleotide MG98 as Cancer Therapy
Robert J. Amato
  • Abstract
  • No Access
  • Add to Cart
Original Contributions
Page Number of this Article in the Print Version
427-432		 Treatment of Advanced Renal Cell Carcinoma with the Combination Bevacizumab/Erlotinib/Imatinib: A Phase I/II Trial
John D. Hainsworth, David R. Spigel, Jeffrey A. Sosman, Howard A. Burris III, Cindy Farley, Heather Cucullu, Kathleen Yost, Lowell L. Hart, Linda Sylvester, David M. Waterhouse, F. Anthony Greco
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
433-437		 The AKT Inhibitor Perifosine in Biochemically Recurrent Prostate Cancer: A Phase II California/Pittsburgh Cancer Consortium Trial
Karen G. Chee, Jeff Longmate, David I. Quinn, Gurkamal Chatta, Jacek Pinski, Przemyslaw Twardowski, Chong-Xian Pan, Angelo Cambio, Christopher P. Evans, David R. Gandara, Primo N. Lara Jr
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
438-445		 Characteristics of Synchronous- and Metachronous-Type Multiple Primary Neoplasms: A Study of Hospital-Based Cancer Registry in Turkey
Sevil Kilciksiz, Tumay Gokce, Ali Baloglu, Aylin Callı, Canan Kaynak, Bülent Kilic, Erkan Eski, Gülten Nalbantoglu, Hacer Ari Yigitbas
  • Abstract
  • No Access
  • Add to Cart
Case Reports
Page Number of this Article in the Print Version
446-451		 Prolonged Complete Responses and Near-Complete Responses to Sunitinib in Metastatic Renal Cell Carcinoma
Daniel Y. C. Heng, Brian I. Rini, Jorge Garcia, Laura Wood, Ronald M. Bukowski
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
452-454		 Sarcomatoid Collecting-Duct Carcinoma of the Kidney
Slim Charfi, Lobna Ayadi, Sameh Ellouze, Abdelmajid Khabir, Imen Chtourou, Naourez Gouiaa, Ibticem Bahri, Tahya Sellami-Boudawara
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
455-456		 A New Case of Signet Ring Cell Carcinoma of the Prostate
Amine Derouiche, Akrem Ouni, Nadia Kourda, Karim Belhadj, Sarra Ben Jilani, Mohamed Chebil
  • Abstract
  • No Access
  • Add to Cart
Current Trials
Page Number of this Article in the Print Version
457-459		 Phase II Study of Azacitidine to Restore Responsiveness of Prostate Cancer to Hormonal Therapy
Guru Sonpavde, Ana Aparicio, Israel Guttierez, Kristi A. Boehm, Thomas E. Hutson, William R. Berry, Lina Asmar, Daniel D. von Hoff
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
460-463		 Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Maintenance Sunitinib Versus Placebo After Chemotherapy for Patients with Advanced Urothelial Carcinoma: Scientific Rationale and Study Design
Deborah A. Bradley, Rodney Dunn, David Nanus, Walter Stadler, Robert Dreicer, Jonathan Rosenberg, David C. Smith, Maha Hussain
  • Abstract
  • No Access
  • Add to Cart
Clinical Trials
Page Number of this Article in the Print Version
464-465		 Selected Clinical Trials in Renal Cell Carcinoma and Prostate Cancer
CIG Media Group
  • Abstract
  • No Access
  • Add to Cart